Study on Anti-inflammatory and Anti-oxidative Stress Mechanism of Sitagliptin: a Dipeptidyl Peptidase-4 Inhibitor
The prevalence rate of type 2 diabetes is increasing year by year. It is known that oxidative stress and inflammation can participate in the occurrence and development of diabetes. Dipeptidyl peptidase-4 (DPP-4) inhibitors can enhance the incretin effect by inhibiting DPP-4, thus playing a hypoglyce...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese General Practice Publishing House Co., Ltd
2025-04-01
|
| Series: | Zhongguo quanke yixue |
| Subjects: | |
| Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/20240268.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The prevalence rate of type 2 diabetes is increasing year by year. It is known that oxidative stress and inflammation can participate in the occurrence and development of diabetes. Dipeptidyl peptidase-4 (DPP-4) inhibitors can enhance the incretin effect by inhibiting DPP-4, thus playing a hypoglycemic role, and have been widely used in the treatment of diabetes patients. Currently, studies have shown that DPP-4 expression is up-regulated in a variety of inflammatory diseases, suggesting that it may be involved in the occurrence of inflammation. However, there are few relevant reports on the mechanism of action of DPP-4 inhibitor in inflammation and oxidative stress. Therefore, this paper reviews the anti-inflammatory and antioxidant stress mechanism of sitagliptin, a DPP-4 inhibitor, and proposes that sitagliptin has certain application prospects in the treatment of other diseases, providing references for subsequent relevant studies. |
|---|---|
| ISSN: | 1007-9572 |